Abstract
1. The pharmacokinetics of an α,β-adrenoceptor blocker, amosulalol hydrochloride, were studied after i.v. and oral administration to rats, dogs and monkeys.
2. After an i.v. dose (1 mg/kg), the plasma concentration-time curve fitted a two-compartment open model with terminal half-lives of 2-5 h in rats, 21 h in dogs and 1-8 h in monkeys. The order of plasma clearances for amosulalol was: rats > dogs > monkeys.
3. After oral administration, the maximum plasma concentration was obtained at 0-5-1 h in rats (10-100mg/kg) and dogs (3-30mg/kg), and at l-7-2-7h in monkeys (3-10 mg/kg). A linear relationship between the area under the plasma concentration-time curve and dose administered was obtained for all three species. The systemic availabilities of the drug in rats, dogs and monkeys were 22-31%, 51-59% and 57-66%, respectively.
4. After repeated oral administration (10 mg/kg) to dogs for 15 days, the pharmaco-kinetic parameters did not differ significantly from those on the first day.